Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Optimizing the use of biologic therapies in the treatment of inflammatory bowel disease.

Literature DB >> 21960868

Optimizing the use of biologic therapies in the treatment of inflammatory bowel disease.

Scott E Plevy¹.

Abstract

Entities: Disease

Year: 2007 PMID： 21960868 PMCID： PMC3099294

Source DB: PubMed Journal: Gastroenterol Hepatol (N Y) ISSN： 1554-7914

Keyword Cloud
References

× No keyword cloud information.

3 in total

Review 1. Novel biologics in inflammatory bowel disease.

Authors: Georgios I Papachristou; Scott Plevy
Journal: Gastroenterol Clin North Am Date: 2004-06 Impact factor: 3.806

2. Safety and tolerability of concurrent natalizumab treatment for patients with Crohn's disease not in remission while receiving infliximab.

Authors: Bruce E Sands; Richard Kozarek; Jack Spainhour; Charles F Barish; Scott Becker; Lawrence Goldberg; Seymour Katz; Ronald Goldblum; Rena Harrigan; Deborah Hilton; Stephen B Hanauer
Journal: Inflamm Bowel Dis Date: 2007-01 Impact factor: 5.325

3. Infliximab dose intensification in Crohn's disease.

Authors: Miguel Regueiro; Benjamin Siemanowski; Kevin E Kip; Scott Plevy
Journal: Inflamm Bowel Dis Date: 2007-09 Impact factor: 5.325

3 in total